Compare IQV & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | MTD |
|---|---|---|
| Founded | 1982 | 1991 |
| Country | United States | Switzerland |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 27.8B |
| IPO Year | 2013 | 1997 |
| Metric | IQV | MTD |
|---|---|---|
| Price | $156.40 | $1,265.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | $227.13 | ★ $1,444.17 |
| AVG Volume (30 Days) | ★ 1.3M | 117.3K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.67 | 3.88 |
| EPS | 7.84 | ★ 42.05 |
| Revenue | ★ $9,739,000,000.00 | $4,026,399,000.00 |
| Revenue This Year | $6.77 | $6.07 |
| Revenue Next Year | $5.89 | $4.75 |
| P/E Ratio | ★ $20.30 | $30.35 |
| Revenue Growth | ★ 41.60 | 3.98 |
| 52 Week Low | $134.65 | $1,052.05 |
| 52 Week High | $247.05 | $1,525.17 |
| Indicator | IQV | MTD |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 46.14 |
| Support Level | N/A | $1,256.69 |
| Resistance Level | $193.26 | $1,300.34 |
| Average True Range (ATR) | 5.68 | 37.63 |
| MACD | -1.59 | -6.10 |
| Stochastic Oscillator | 7.16 | 27.15 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.